Ekso Bionics Holdings Inc Stock Deutsche Boerse AG
Equities
US2826441030
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
06-25 | Ekso Bionics Announces Research Partnership with Shepherd Center | CI |
06-24 | Lake Street Starts Coverage on Ekso Bionics With Buy Rating, $2.50 Price Target | MT |
Sales 2024 * | 20.52M 18.83M 28.07M | Sales 2025 * | 28.1M 25.78M 38.45M | Capitalization | 24.9M 22.84M 34.06M |
---|---|---|---|---|---|
Net income 2024 * | -9M -8.26M -12.31M | Net income 2025 * | -4M -3.67M -5.47M | EV / Sales 2024 * | 1.21 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.89 x |
P/E ratio 2024 * |
-2.66
x | P/E ratio 2025 * |
-5.71
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.79% |
Latest transcript on Ekso Bionics Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Scott Davis
CEO | Chief Executive Officer | 54 | 21-03-31 |
Jerome Wong
DFI | Director of Finance/CFO | 50 | 17-04-30 |
Jason Jones
COO | Chief Operating Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corinna Lathan
BRD | Director/Board Member | 56 | 21-12-24 |
Mary Cloyd
BRD | Director/Board Member | 69 | 20-12-28 |
Charles Li
BRD | Director/Board Member | 39 | 18-03-10 |
1st Jan change | Capi. | |
---|---|---|
+2.62% | 208B | |
+6.44% | 182B | |
+29.61% | 155B | |
+34.96% | 115B | |
+2.93% | 66.52B | |
+17.38% | 53.93B | |
-4.51% | 46.26B | |
-5.77% | 38.22B | |
+3.71% | 36.6B |